NLM Digital Collections

Search

Start Over Subjects Formularies as Topic ✖Remove constraint Subjects: Formularies as Topic Subjects Humans ✖Remove constraint Subjects: Humans Publication Year 2000 to 2024 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2000">2000</span> to <span class="to" data-blrl-end="2024">2024</span>

1. State Pharmacy Assistance Programs vs. Medicare prescription drug plans: how do they contain rising costs?

Publication:
[Washington, D.C.] : AcademyHealth, [2005]
Subject(s):
Cost Control
Medicare -- economics
State Health Plans -- economics
Cost Sharing
Drug Costs
Drug Utilization Review
Drugs, Generic
Fees, Pharmaceutical
Formularies as Topic
Insurance Coverage -- legislation & jurisprudence
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- legislation & jurisprudence
Medicare -- legislation & jurisprudence
Humans
United States

2. Part D plans generally include drugs commonly used by dual eligibles: 2018

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Drug Utilization
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Medicare Part D
Insurance Benefits
Insurance, Pharmaceutical Services
Humans
United States
United States. Department of Health and Human Services.
United States.

3. Snapshots of recent state initiatives in Medicaid prescription drug cost control

Author(s):
Young, Katherine, author
Garfield, Rachel, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, February 2018
Subject(s):
Cost Control -- statistics & numerical data
Cost Control -- trends
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicaid -- economics
Medicaid -- trends
Disclosure
Drugs, Generic -- economics
Economics, Pharmaceutical
Federal Government
Forecasting
Formularies as Topic
State Government
Humans
United States
United States. Food and Drug Administration.

5. Prior authorization requirements for proprotein convertase subtilisin/kexin type 9 inhibitors across US private and public payers

Author(s):
Doshi, Jalpa A., author
Puckett, Justin T., author
Parmacek, Michael S., author
Rader, Daniel J., author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
Subject(s):
Eligibility Determination
Insurance Coverage
Insurance, Health
Proprotein Convertase 9 -- antagonists & inhibitors
Serine Proteinase Inhibitors -- economics
Serine Proteinase Inhibitors -- therapeutic use
Economics, Pharmaceutical
Formularies as Topic
Hypercholesterolemia -- drug therapy
Medicaid -- economics
Medicare -- economics
Private Sector
Public Sector
Humans
Pennsylvania
United States

6. The Medicare drug benefit: options for low-income Californians in 2008

Publication:
Oakland, Calif. : California HealthCare Foundation, [2008]
Subject(s):
Eligibility Determination
Insurance Coverage
Insurance, Pharmaceutical Services -- statistics & numerical data
Medicare -- economics
Data Collection
Drug Costs -- statistics & numerical data
Formularies as Topic
Poverty
Humans
California
United States
Centers for Medicare & Medicaid Services (U.S.)

7. Value-based coverage policy in the United States and the United Kingdom: different paths to a common goal

Publication:
Washington, D.C. : George Washington University, [2006]
Subject(s):
Cost-Benefit Analysis
Evidence-Based Medicine
Insurance Coverage -- economics
Technology Assessment, Biomedical
Formularies as Topic
Medicaid -- economics
Medicare -- economics
Private Sector
State Government
Humans
United Kingdom
United States
United States. Agency for Healthcare Research and Quality.
Blue Cross Association.
Blue Shield Association.
Centers for Medicare & Medicaid Services (U.S.)
National Institute for Health and Clinical Excellence (Great Britain)

8. Part D plans generally include drugs commonly used by dual eligibles: 2017

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2017
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- statistics & numerical data
Drug Utilization
Medicare Part D -- economics
Humans
United States
United States. Department of Health and Human Services.
United States.

10. Veterans affairs contracting: improvements in buying medical and surgical supplies could yield cost savings and efficiency : testimony before the Committee on Veterans' Affairs, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, December 7, 2017
Subject(s):
Purchasing, Hospital -- economics
Veterans Health -- economics
Contract Services
Cost Control
Cost Savings
Economic Competition
Equipment and Supplies -- economics
Formularies as Topic
Humans
United States
United States. Department of Veterans Affairs.